Physician profile
Edward Foley
NPI 1992739577
$643.48
in general payments reported to CMS, 2019-2025
12 companies · $22.59 in 2025
The $22.59 reported for 2025 was less than what a typical Adolescent Medicine (Pediatrics) provider received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67.77 · 2020: $56.42 · 2021: $78.41 · 2022: $98.28 · 2023: $122 · 2024: $198 · 2025: $22.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $343.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $342.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $247.29 | 2019-2025 | Bexsero, Rotarix, Pediarix |
| Sanofi Pasteur INC. | $131.00 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $67.73 | 2020-2024 | Vaxelis, M-M-R II, Gardasil 9 |
| Alexion Pharmaceuticals, INC. | $37.75 | 2019-2024 | Ultomiris |
| Lilly USA, LLC | $25.73 | 2023 | Jardiance |
| Abbvie INC. | $25.03 | 2024 | |
| Corium, LLC | $23.65 | 2022 | |
| Novo Nordisk INC | $20.11 | 2024 | |
| Ironshore Pharmaceuticals INC. | $19.30 | 2024 | |
| Verrica Pharmaceuticals INC. | $16.43 | 2024 | Ycanth |
| Cranial Technologies, INC | $16.01 | 2021 | |
| Pfizer INC. | $13.45 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Foley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.